• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Oka Mikio  岡 三喜男

ORCIDConnect your ORCID iD *help
… Alternative Names

OKA Mikio  岡 三喜男

Less
Researcher Number 40223995
Other IDs
Affiliation (Current) 2025: 川崎医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2022 – 2025: 川崎医科大学, 医学部, 教授
2017: 川崎医科大学, 医学部・呼吸器内科学, 教授
2015 – 2017: 川崎医科大学, 医学部, 教授
2008 – 2013: Kawasaki Medical School, 医学部, 教授
2004: Kawasaki Medical School, Department of Medicine, Professor, 医学部, 教授
2002 – 2003: 長崎大学, 大学院・医歯薬学総合研究科, 助教授
Review Section/Research Field
Principal Investigator
Respiratory organ internal medicine / Basic Section 53030:Respiratory medicine-related / Respiratory organ internal medicine
Except Principal Investigator
Basic Section 53030:Respiratory medicine-related / Basic Section 53050:Dermatology-related / Tumor biology / Tumor therapeutics
Keywords
Principal Investigator
がん免疫療法 / がん抗原 / バイオマーカー / 免疫モニタリング / 予後因子 / 腫瘍免疫 / 肺がん / がん精巣抗原 / 肺癌 / モニタリング … More / 肺腺がん / がん免疫応答 / 個別化医療 / 抗体療法 / 免疫チェックポイント / がん免疫 / Breast Cancer Resistance Protein / Telomerase / Histone Deareryinse Inhibitor / Topoisomerase Inhibitor / Drug Transporter Protpin / Lang Cancer / Cancer Chemotherapy / Drug Resistance / 茎剤輸送蛋白 / 乳癌耐性蛋白 / テロメラーゼ / ヒストン脱アセチル化阻害剤 / トポイソメラーゼ阻害薬 / 薬剤輸送蛋白 / 癌化学療法 / 薬剤耐性 / 免疫調節薬 / 臨床試験 / 抗体産生 / 制御性T細胞 / がんワクチン / 癌免疫療法 / ペプチドワクチン / 癌ワクチン / 癌精巣抗原 / CT画像 / 胸部CT / サウンドスペクトログラム / 医用工学 / 肺聴診学 / デジタル肺音 / 電子聴診器 / 肺音 … More
Except Principal Investigator
免疫チェックポイント阻害薬 / バイオマーカー / TIM-3 / PD-1 / XAGE1 / 肺がん / XAGE1抗原 / irAE / 皮膚悪性腫瘍 / 血清NY-ESO-1/XAGE1抗体 / がん精巣抗原 / NY-ESO-1 / NSCLC / TAA / cancer-testis antigens / 非小細胞肺癌 / 腫瘍浸潤リンパ球 / PD-L1 / Treg / 制御性T細胞 / 肺癌微小環境 / 免疫活性化 / 癌 / 免疫チェックポイント / Galectin-9 / 肺癌 / 免疫チェックポイント分子 / 免疫療法 / がん抗原 Less
  • Research Projects

    (10 results)
  • Research Products

    (130 results)
  • Co-Researchers

    (11 People)
  •  肺腺がん特異的に発現するXAGE1抗原を標的にした診断薬と治療法の特許開発

    • Principal Investigator
      黒瀬 浩史
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Kawasaki Medical School
  •  肺がん免疫療法の効果をモニタリングする血清マーカーの特許開発Principal Investigator

    • Principal Investigator
      岡 三喜男
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Kawasaki Medical School
  •  皮膚悪性腫瘍に対する免疫療法の効果及びirAE発症を予測する血清バイオマーカーの開発

    • Principal Investigator
      田中 了
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53050:Dermatology-related
    • Research Institution
      Kawasaki Medical School
  •  肺がん免疫療法の効果を予測する多抗原性血清抗体検出パネルの臨床開発

    • Principal Investigator
      黒瀬 浩史
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Kawasaki Medical School
  •  Identification of immunosuppressive factor in tumor microenvironment in patient with lung cancer

    • Principal Investigator
      Ohue Yoshihiro
    • Project Period (FY)
      2016 – 2017
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Kawasaki Medical School
  •  Identification of tumor microenvironment involving tumor infiltrating regulatory T cells in lung cancer

    • Principal Investigator
      Kurose Koji
    • Project Period (FY)
      2016 – 2017
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor biology
    • Research Institution
      Kawasaki Medical School
  •  Development of immunotherapy for lung adenocarcinoma using XAGE1 antigen and serum antibody as biomarkersPrincipal Investigator

    • Principal Investigator
      Oka Mikio
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Respiratory organ internal medicine
    • Research Institution
      Kawasaki Medical School
  •  Development of cancer vaccines targeting the cancer/testis antigen XAGE highly-expressed in lung adenocarcinomaPrincipal Investigator

    • Principal Investigator
      OKA Mikio
    • Project Period (FY)
      2011 – 2013
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Respiratory organ internal medicine
    • Research Institution
      Kawasaki Medical School
  •  Relationship between chest CT findings and digital lung sounds collected by electronic stethoscopePrincipal Investigator

    • Principal Investigator
      OKA Mikio
    • Project Period (FY)
      2008 – 2010
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Respiratory organ internal medicine
    • Research Institution
      Kawasaki Medical School
  •  Development of anti-lung cancer drugs overcoming drug resistance mediated by new molecules a drug efflux pump, breast cancer resistance protein (BCRP), and topoisomerase-I inhibitorPrincipal Investigator

    • Principal Investigator
      OKA Mikio
    • Project Period (FY)
      2002 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Respiratory organ internal medicine
    • Research Institution
      Kawasaki Medical School
      Nagasaki University

All 2023 2022 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2006 2005 2004 2003 2002 Other

All Journal Article Presentation Book Patent

  • [Book] 読んで見てわかる免疫腫瘍学2017

    • Author(s)
      岡 三喜男
    • Total Pages
      170
    • Publisher
      中外医学社
    • ISBN
      9784498022645
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Book] 特集 肺癌免疫療法の新たな展開 免疫チェックポイントの役割とその阻害2016

    • Author(s)
      岡三喜男, 大植祥弘
    • Total Pages
      115
    • Publisher
      日本胸部臨床
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Book] 肺聴診学:読んで学ぶ肺の聴診2012

    • Author(s)
      岡三喜男
    • Total Pages
      30
    • Publisher
      自費出版(実習参考書)
    • Data Source
      KAKENHI-PROJECT-20590937
  • [Book] 川崎医科大学呼吸器内科発行、肺音学:読んで学ぶ肺の聴診2012

    • Author(s)
      岡三喜男
    • Total Pages
      25
    • Data Source
      KAKENHI-PROJECT-20590937
  • [Book] EBM呼吸器疾患の治療 2006-2007(永井厚志, 吉澤靖之、編)2005

    • Author(s)
      福田 実, 早田 宏, 岡 三喜男
    • Total Pages
      574
    • Publisher
      中外医学社
    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Book] 癌化学療法Update(西條長宏, 鶴尾隆、編集)2005

    • Author(s)
      岡 三喜男, 福田 実, 早田 宏
    • Total Pages
      524
    • Publisher
      中外医学社
    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Book] プラクテイカル内科シリーズ 肺癌 改訂第2版(福岡正博, 西條長宏、編集)2003

    • Author(s)
      岡 三喜男(分担執筆)
    • Total Pages
      273
    • Publisher
      南江堂
    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers2023

    • Author(s)
      Kurose Koji、Sakaeda Kanako、Fukuda Minoru、Sakai Yumiko、Shimizu Katsuhiko、Tanaka Ryo、Hasegawa Takehiro、Atarashi Yusuke、Irino Yasuhiro、Sato Toshiyuki、Inoue Hiromasa、Hattori Noboru、Kanda Eiichiro、Nakata Masao、Mukae Hiroshi、Oga Toru、Oka Mikio
    • Journal Title

      Advances in Clinical Chemistry

      Volume: 112 Pages: 155-204

    • DOI

      10.1016/bs.acc.2022.09.004

    • ISBN
      9780443192845
    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08247, KAKENHI-PROJECT-22K08346
  • [Journal Article] NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC2017

    • Author(s)
      Takeoka T, Nagase H, Kurose K, Ohue Y, Yamasaki M, Takiguchi S, Sato E, Isobe M, Kanazawa T, Matsumoto M, Iwahori K, Kawashima A, Morimoto-Okazawa A, Nishikawa H, Oka M, Pan L, Venhaus R, Nakayama E, Mori M, Doki Y, Wada H.
    • Journal Title

      J Immunother

      Volume: epub Issue: 4 Pages: 140-147

    • DOI

      10.1097/cji.0000000000000162

    • Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18463, KAKENHI-PROJECT-26290054, KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-16K21533, KAKENHI-PROJECT-16K15551, KAKENHI-PROJECT-17H06162
  • [Journal Article] Biomarkers for differentiation of patients with asthma and chronic obstractive pulmonary disease.2017

    • Author(s)
      Katoh S, Ikeda M, Shirai R, Abe M, Ohue Y, Kobashi Y, Oka M.
    • Journal Title

      Journal of Asthma

      Volume: 16 Issue: 10 Pages: 1-7

    • DOI

      10.1080/02770903.2017.1391281

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-16K18463
  • [Journal Article] Beneficial effects of Galectin-9 on allergen-specific sublingual immunotherapy in a <i>Dermatophagoides farinae</i>-induced mouse model of chronic asthma2017

    • Author(s)
      Ikeda M, Katoh S, Shimizu H, Oka M.
    • Journal Title

      Allergol. Int.

      Volume: 66 Issue: 3 Pages: 432-439

    • DOI

      10.1016/j.alit.2016.10.007

    • NAID

      130005858794

    • ISSN
      1323-8930, 1440-1592
    • Language
      English
    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Journal Article] Possible role of IL-25 in eosinophilic lung inflammation in patients with chronic eosinophilic pneumonia.2017

    • Author(s)
      Katoh S, Ikeda M, Matsumoto N, Shimizu H, Abe M, Ohue Y, Mouri K, Nakazato M, Oka M.
    • Journal Title

      Lung

      Volume: 195 Issue: 6 Pages: 707-712

    • DOI

      10.1007/s00408-017-0048-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-16K18463
  • [Journal Article] Survival of lung adenocarcinoma patients predicted from expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on tumor cells and tumor-infiltrating T cells.2016

    • Author(s)
      Ohue Y, Kurose K, Nozawa R, Isobe M, Nishio Y, Tanaka T, Doki Y, Hori T, Fukuoka J, Oka M, Nakayama E.
    • Journal Title

      Clinical Cancer Research

      Volume: 4 Pages: 1049-1060

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Journal Article] Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells.2016

    • Author(s)
      Ohue Y, Kurose K, Nozawa R, Isobe M, Nishio Y, Tanaka T, Doki Y, Hori T, Fukuoka J, Oka M, Nakayama E
    • Journal Title

      Cancer Immunology Research

      Volume: 4 Pages: 1049-1060

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-16K21533
  • [Journal Article] Drug fever after cancer chemotherapy is most commonly observed on post treatment days 3-4.2016

    • Author(s)
      Ogawara D, Fukuda M, Ueno S, Ohue Y, Takemoto S, Mizoguchi K, Nakatomi K, Nakamura Y, Obase Y, Honda T, Tsukamoto K, Ashizawa K, Oka M, Kohno S.
    • Journal Title

      Supportive Care in Cancer

      Volume: 24 Issue: 2 Pages: 615-619

    • DOI

      10.1007/s00520-015-2820-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Journal Article] Development of two types of mite-allergen induced murine models of chronic asthma with different severity.2016

    • Author(s)
      Ikeda M, Katoh S, Shimizu H, Oka M.
    • Journal Title

      Kawasaki Medical Journal

      Volume: 42 Pages: 1-7

    • NAID

      110010041931

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Journal Article] Pulmonary M. scrofulaceum disease showing false-positive response of anti-GPL core IgA antibody.2016

    • Author(s)
      Kobashi Y, Mouri K, Kato S, Oka M.
    • Journal Title

      Infection Diseases (Lond)

      Volume: 48 Pages: 767-768

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Journal Article] Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells2016

    • Author(s)
      Ohue Y, Kurose K, Nozawa R, Isobe M, Nishio Y, Tanaka T, Doki Y, Hori T, Fukuoka J, Oka M, Nakayama E.
    • Journal Title

      Cancer Immunol Res

      Volume: 12 Pages: 1049-1060

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Journal Article] Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients.2015

    • Author(s)
      Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Kojima T, Doi T, Suzuki S, Isobe M, Funakoshi T, Kakimi K, Nishikawa H, Udono H, Oka M, Ueda R, Nakayama E.
    • Journal Title

      Clinical Cancer Research

      Volume: 21 Pages: 4327-4336

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Journal Article] Chemotherapy2015

    • Author(s)
      Kasai T, Nakamura Y, Fukuda M, Kitazaki T, Nagashima S, Takatani H, Nakano H, Nakatomi K, Ikeda T, Yamaguchi H, Tsukamoto K, Oka M, Kohno S.
    • Journal Title

      Phase II study of S-1 for previously untreated elderly patients with advanced non-small cell lung cancer.

      Volume: 61 Issue: 2 Pages: 93-98

    • DOI

      10.1159/000441486

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-25460691
  • [Journal Article] Contrasting effects of the cytotoxic anticancer drug Gemcitabine and the EGFR tyrosine kinase inhibitor Gefitinib on NK cell-mediated cytotoxicity via regulation of NKG2D ligand in non-small-cell lung cancer cells.2015

    • Author(s)
      Okita R, Wolf D, Yasuda K, Maeda A, Yukawa T, Saisho S, Shimizu K, Yamaguchi Y, Oka M, Nakayama E, Lundqvist A, Kiessling R, Seliger B, Nakata M.
    • Journal Title

      PLoS One

      Volume: 10 Issue: 10 Pages: e0139809-e0139809

    • DOI

      10.1371/journal.pone.0139809

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-25430161, KAKENHI-PROJECT-25462189
  • [Journal Article] TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl- cysteaminyl-phenolmaleimid-dextran (NPCMD)2014

    • Author(s)
      Mizote Y, Wakamatsu K, Ito S, Uenaka A, Ohue Y, Kurose K, Isobe M, Ito A, Tamura Y, Honda H, Yamashita T, Nohara S, Oka M, Jimbow K, Nakayama E.
    • Journal Title

      J Dermatol Sci.

      Volume: 73(3) Pages: 209-15

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen2014

    • Author(s)
      Wada H, Isobe M, Kakimi K, Mizote Y, Eikawa S, Sato E, Takigawa N, Kiura K, Tsuji K, Iwatsuki K, Yamasaki M, Miyata H, Matsushita H, Udono H, Seto Y, Yamada K, Nishikawa H, Pan L, Venhaus R, Oka M, Doki Y, Nakayama E.
    • Journal Title

      J Immunother

      Volume: 37(2) Issue: 2 Pages: 84-92

    • DOI

      10.1097/cji.0000000000000017

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23300354, KAKENHI-PROJECT-23591169, KAKENHI-PROJECT-24501329, KAKENHI-PROJECT-25430148, KAKENHI-PROJECT-25430161, KAKENHI-PROJECT-25462014, KAKENHI-PROJECT-25670399, KAKENHI-PROJECT-26290054, KAKENHI-PROJECT-26670581
  • [Journal Article] TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimid-dextran (NPCMD).2014

    • Author(s)
      Mizote Y, Wakamatsu K, Ito S, Uenaka A, Ohue Y, Kurose K, Isobe M, Ito A, Tamura Y, Honda H, Yamashita T, Nohara S, Oka M, Jimbow K, Nakayama E.
    • Journal Title

      Journal of Dermatological Science

      Volume: 73 Pages: 209-215

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and their use for ex vivo detection of CD4 T-cell responses in the vaccinated cancer patients.2014

    • Author(s)
      Mizote, Y, Uenaka A, Isobe M, Wada H, Kakimi K, Saika T, Kita S, Koide Y, Oka M, Nakayama E.
    • Journal Title

      Vaccine

      Volume: 32 Pages: 957-964

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] Genetic variants of immunoglobulin gamma and kappa chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer2014

    • Author(s)
      Pandey JP, Namboodiri AM, Ohue Y, Oka M, Nakayama E.
    • Journal Title

      Clin Exp Immunol

      Volume: 176(1) Pages: 78-83

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer.2014

    • Author(s)
      Pandey JP, Namboodiri AM, Ohue Y, Oka M, Nakayama E.
    • Journal Title

      Clinical Experimental Immunology

      Volume: 176 Issue: 1 Pages: 78-83

    • DOI

      10.1111/cei.12247

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169, KAKENHI-PROJECT-25430161
  • [Journal Article] Production of NY-ESO-1 peptide /DRB1*08:03 tetramers and their use for ex vivo detection of CD4 T-cell responses in the vaccinated cancer patients2014

    • Author(s)
      Mizote, Y, Uenaka A, Isobe M, Wada H, Kakimi K, Saika T, Kita S, Koide Y, Oka M, Nakayama E.
    • Journal Title

      Vaccine

      Volume: 32(8) Pages: 957-64

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide2013

    • Author(s)
      Eikawa S, Kakimi K, Isobe M, Kazushima K, Luescher I, Ohue Y, Ikeuchi K, Uenaka A, Nishikawa H, Udono H, Oka M, Nakayama E.
    • Journal Title

      Int J Cancer

      Volume: 132(2) Pages: 345-54

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide.2013

    • Author(s)
      Eikawa, S., Kakimi, K., Idobe, M., Kuzushima, K., Luescher, I., Ohue, Y., Ikeuchi, K., Uenaka, A., Nishikawa, H., Udono, H., Oka, M., and Nakayama, E.
    • Journal Title

      Int. J. Cancer

      Volume: 132(2) Issue: 2 Pages: 345-54

    • DOI

      10.1002/ijc.27682

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22300332, KAKENHI-PROJECT-22501027, KAKENHI-PROJECT-23300354, KAKENHI-PROJECT-23591169, KAKENHI-PROJECT-24501329
  • [Journal Article] 抗CCR4抗体と制御性T細胞2013

    • Author(s)
      黒瀬浩史、大植祥弘、岡三喜男
    • Journal Title

      癌と化学療法

      Volume: 第8巻第10号 Pages: 1150-1155

    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients2012

    • Author(s)
      Ohue Y, Eikawa S, Okazaki N, Mizote Y, Isobe M, Uenaka A, Fukuda M, Old LJ, Oka M, Nakayama E.
    • Journal Title

      Int J Cancer

      Volume: 131(5)

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] Spontaneous antibody, and CD4 and CD8T-cell responses against XAGE-1b(GAGED2a) in non-small cell lung cancer patients.2012

    • Author(s)
      Ohue, Y., Eikawa, S., Okazaki, N., Mizote, Y., Isobe, M., Uenaka, A., Fukuda M., Old, L.J., Oka, M., and Nakayama, E.
    • Journal Title

      Int. J. Cancer

      Volume: 131(5) Issue: 5

    • DOI

      10.1002/ijc.27359

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22300332, KAKENHI-PROJECT-23591169
  • [Journal Article] 肺音の聴診学習支援システムの検討2011

    • Author(s)
      滝川雄、薗田光太郎、喜安千弥、宮原末治、大藤貴、岡三喜男
    • Journal Title

      薬理と臨床

      Volume: 21巻 Pages: 179-183

    • Data Source
      KAKENHI-PROJECT-20590937
  • [Journal Article] A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing NY-ESO-1 antigen2011

    • Author(s)
      Kakimi K, Isobe M, Uenaka A, Wada H, Sato E, Doki Y, Nakajima J, Seto Y, Yamatsuji T, Oka M, Pan L, Hoffman EW, Old LJ, Nakayama E.
    • Journal Title

      Int J Cancer

      Volume: 129(12) Pages: 2836-46

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Journal Article] 肺音のための識別辞書構成法の検討2010

    • Author(s)
      滝川雄、藤原直哉、喜安千弥、宮原末治、岡三喜男
    • Journal Title

      薬理と臨床

      Volume: 20巻 Pages: 281-285

    • Data Source
      KAKENHI-PROJECT-20590937
  • [Journal Article] 多重解像度解析による肺音からの呼吸周期検出2010

    • Author(s)
      宮原末治、喜安千弥、薗田光太郎、岡三喜男
    • Journal Title

      情報処理学会情報科学技術フォーラム

      Volume: FIT2010

    • Data Source
      KAKENHI-PROJECT-20590937
  • [Journal Article] BCRP/ABCGII levels account for the resistance to topoisomerase I inhibitors2006

    • Author(s)
      Nagashima S, Oka M. et al.
    • Journal Title

      Cancer Chemotherapy and Pharmacology 58

      Pages: 594-600

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase II study of irinotecan combined with carboplatin in previously untrea2006

    • Author(s)
      Kinoshita A, Fukuda M, Oka M, et al.
    • Journal Title

      British Journal of Cancer 94

      Pages: 1267-1271

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer.2006

    • Author(s)
      Nagashima S, Soda H, Oka M, ef al.
    • Journal Title

      Cancer Chemother Pharmacol 58

      Pages: 594-600

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer.2006

    • Author(s)
      Kinoshita A, Soda H, Oka M, ef al.
    • Journal Title

      British Journal of Cancer 94

      Pages: 1267-1271

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.2005

    • Author(s)
      Nakamura Y, Oka M, Soda H, ef al.
    • Journal Title

      Cancer Research 65

      Pages: 1541-1546

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Gefitinib (Iressa,ZD1839), an EGFR tyrosine kinase inhibitor, reverses brea2005

    • Author(s)
      Nakamura Y, Oka M. et al.
    • Journal Title

      Cancer Research 65

      Pages: 1541-1546

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Gefitinib (Iressa, ZD1839), an EGFR tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance2005

    • Author(s)
      Nakamura Y, Oka M, et al.
    • Journal Title

      Cancer Research 65

      Pages: 1541-1546

    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells.2005

    • Author(s)
      Kitazaki T, Oka M, Soda H, ef al.
    • Journal Title

      Lung Cancer 49

      Pages: 337-347

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] 抗がん剤とABCトランスポーター2005

    • Author(s)
      岡 三喜男, 福田 実, 早田 宏
    • Journal Title

      癌と化学療法 32

      Pages: 585-592

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Gefitinib, and EGFR tyrosine kinase inhibitor, directly inhibits the function o2005

    • Author(s)
      Kitazaki T, Oka M. et al.
    • Journal Title

      Lung Cancer 49

      Pages: 337-347

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase II study of irinotecan combined with carboplatin in previously untreated non-small cell lung cancer2004

    • Author(s)
      Fukuda M, Oka M, et al.
    • Journal Title

      Cancer Chemotherapy and Pharmacology 54

      Pages: 573-577

    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells.2004

    • Author(s)
      Yoshikawa M, Oka M, ef al.
    • Journal Title

      International Journal of Cancer 110

      Pages: 921-927

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells.2004

    • Author(s)
      Doi S, Soda H, Oka M, ef al.
    • Journal Title

      Molecular Cancer Therapeutics 3

      Pages: 1397-1402

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, acoumermycin antibiotic.2004

    • Author(s)
      Shiozawa K, Oka M, Soda H, ef al.
    • Journal Title

      International Journal of Cancer 108

      Pages: 146-151

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer.2004

    • Author(s)
      Fukuda M, Oka M, Soda H, ef al.
    • Journal Title

      Cancer Chemotherapy and Pharmacology 54

      Pages: 573-577

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells2004

    • Author(s)
      Doi S, Oka M, et al.
    • Journal Title

      Molecular Cancer Therapeutics 3

      Pages: 1397-1402

    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Reversal of breast cancer resistance protein (BCRP/ACBG2)-mediated drug resistanc2004

    • Author(s)
      Shiozawa K, Oka M. et al.
    • Journal Title

      International Journal of Cancer 108

      Pages: 146-151

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells2004

    • Author(s)
      Yoshikawa M, Oka M, et al.
    • Journal Title

      International Journal of Cancer 110

      Pages: 921-927

    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic2004

    • Author(s)
      Shiozawa K, Oka M, et al.
    • Journal Title

      International Journal of Cancer 108

      Pages: 146-151

    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] The histone deacetylase inhibitor FR901228 induces caspase-dependent apop2004

    • Author(s)
      Doi S, Soda H, Oka M, et al.
    • Journal Title

      Molecular Cancer Therapeutics 3

      Pages: 1397-1402

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in2004

    • Author(s)
      Yoshikawa M, Oka M. et al.
    • Journal Title

      International Journal of Cancer 110

      Pages: 921-927

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase II study of irinotecan combined with carboplatin in previously untreated non-s2004

    • Author(s)
      Fukuda M, Oka M. et al.
    • Journal Title

      Cancer Chemotherapy and Pharmacology 54

      Pages: 573-577

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Expression of heat shock protein (Hsp) 70 and Hsp 40 in colorectal cancer.2003

    • Author(s)
      Kanazawa Y, Oka M, ef al.
    • Journal Title

      Medical Oncology 20

      Pages: 157-164

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer2003

    • Author(s)
      Isomoto H, Oka M. et al.
    • Journal Title

      Cancer Letter 198

      Pages: 219-228

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Expression and functional analyses of breast cancer resistance protein in lung cance2003

    • Author(s)
      Kawabata S, Oka M, et al.
    • Journal Title

      Clinical Cancer Research 9

      Pages: 3025-3057

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.2003

    • Author(s)
      Tsurutani J, Oka M, Soda H, ef al.
    • Journal Title

      International Journal of Cancer 104

      Pages: 238-242

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines2003

    • Author(s)
      Tsurutani J, Soda H, Oka M, et al.
    • Journal Title

      International Journal of Cancer 104

      Pages: 238-242

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Expression and functional analyses of breast cancer resistance protein in lung cancer.2003

    • Author(s)
      Kawabata S, Oka M, Soda H, ef al.
    • Journal Title

      Clinical Cancer Research 9

      Pages: 3052-3057

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Expression of heat shock protein (Hsp) 70 and Hsp 40 in colorectal cance2003

    • Author(s)
      Kanazawa Y, Oka M, et al.
    • Journal Title

      Medical Oncology 20

      Pages: 157-164

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer.2003

    • Author(s)
      Isomoto H, Oka M, ef al.
    • Journal Title

      Cancer Letter 198

      Pages: 219-228

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer.2002

    • Author(s)
      Oka M, Soda H, ef al.
    • Journal Title

      European Journal of Cancer 38

      Pages: 1998-2004

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Mutational analysis of the beta-tublin gene in ling cancer2002

    • Author(s)
      Tsurutani J, Komiya T, Oka M. et al.
    • Journal Title

      Lung Cancer 35

      Pages: 11-16

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with2002

    • Author(s)
      Kasai T, Oka M, Soda H, et al.
    • Journal Title

      European Journal of Cancer 38

      Pages: 1871-1878

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer.2002

    • Author(s)
      Kasai T, Oka M, Soda H, et al.
    • Journal Title

      European Journal of Cancer 38

      Pages: 1871-1878

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.2002

    • Author(s)
      Suenaga M, Soda H, Oka M, ef al.
    • Journal Title

      International Journal of Cancer 97

      Pages: 621-625

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] 肺癌の抗癌剤耐性の分子機構2002

    • Author(s)
      岡 三喜男
    • Journal Title

      呼吸 21

      Pages: 779-787

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy2002

    • Author(s)
      Oka M, Fukuda M, Soda H, et al.
    • Journal Title

      European Journal of Cancer 38

      Pages: 1998-2004

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA2002

    • Author(s)
      Suenaga M, Soda H, Oka M, et al.
    • Journal Title

      International Journal of Cancer 97

      Pages: 621-625

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Journal Article] Mutational analysis of the beta-tubulin gene in lung cancer.2002

    • Author(s)
      Tsurutani J, Oka M, et al.
    • Journal Title

      Lung Cancer 35

      Pages: 11-16

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-14570557
  • [Patent] がん治療効果の検査方法及び免疫応答誘導用組成物2017

    • Inventor(s)
      大植祥弘、黒瀬浩史、岡 三喜男、中山 睿一
    • Industrial Property Rights Holder
      大植祥弘、黒瀬浩史、岡 三喜男、中山 睿一
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2017-094986
    • Filing Date
      2017
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] 非小細胞肺がんの周術期におけるがん免疫応答の解析 周術期免疫チェックポイント療法の血清バイオマーカー開発へ向けて2023

    • Author(s)
      黒瀬浩史、清水克彦、最相晋輔、榮田 佳那子、阪井 裕美子、柳田匡俊、佐藤利幸、小賀 徹、中田昌男、岡 三喜男
    • Organizer
      第20回日本免疫治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K08247
  • [Presentation] 肺がん免疫チェックポイント療法の効果を予測する血清バイオマーカーの全自動測定法の開発2023

    • Author(s)
      黒瀬浩史、渡辺安奈、福田 実、菅崎七枝、木下明敏、北崎 健、福田正明、益田 武、竹本真之輔、松村勇輝、武藤哲史、榮田佳那子、新 勇介、佐藤利幸、服部 登、迎 寛、鈴木弘行、小賀 徹、岡 三喜男
    • Organizer
      第64回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K08247
  • [Presentation] 非小細胞肺癌における免疫チェックポイント阻害薬の効果を予測する自動化測定法の開発2023

    • Author(s)
      黒瀬浩史、福田実、北崎健、福田正明、菅崎七枝、木下明敏、益田武、服部登、竹本真之輔、榮田佳那子、新勇介、佐藤利幸、迎寛、小賀徹、岡三喜男
    • Organizer
      第63回日本呼吸器学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K08247
  • [Presentation] 肺がん免疫チェックポイント療法の効果をモニタリングする血清バイオマーカーの開発2022

    • Author(s)
      黒瀬浩史、福田 実、菅崎七枝、木下明敏、北崎 健、福田正明、竹本真之輔、山口博之、最相晋輔、清水克彦、榮田佳那子、新 勇介、入野康宏、佐藤利幸、中田昌男、迎 寛、小賀 徹、岡 三喜男
    • Organizer
      第63回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K08247
  • [Presentation] Clinical significance of humoral immunity against XAGE1 cancer-testis antigen in lung adenocarcinoma.2018

    • Author(s)
      Oka M, Kurose K, Isobe M, Fukuda M, Ohue Y.
    • Organizer
      ASCO-SITC (American Society of Clinical Oncology - Society for Immunotherapy of Cancer)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Reviving chemotherapy sensitivity after anti-CCR4 mAb (mogamulizumab) treatment in lung cancer patients2018

    • Author(s)
      黒瀬 浩史, 大植 祥弘, 磯辺 みどり, 鈴木 進, 和田 尚, 上田 龍三, 中山 睿一, 岡 三喜男
    • Organizer
      第15回日本免疫治療学研究会学術集会
    • Data Source
      KAKENHI-PROJECT-16K21533
  • [Presentation] Correlation of Clinical Response and XAGE1 Immunity in Lung Adenocarcinoma.2017

    • Author(s)
      Ohue Y, Kurose K, Isobe M, Fukuda M, Nakayama E, Oka M
    • Organizer
      IASLC 18th World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Correlation of Clinical Response and XAGE1 Immunity in Lung Adenocarcinoma.2017

    • Author(s)
      Ohue Y, Kurose K, Isobe M, Fukuda M, Nakayama E, Oka M.
    • Organizer
      IASLC 18th World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Immuno-inhibitory pathway, TIM-3/Galectin-9, in lung adenocarcinoma: clinical and in vitro analysis.2017

    • Author(s)
      Oka M, Ohue Y, Kurose K, Nishio Y, Isobe M, Nakayama E.
    • Organizer
      101st Annual Meeting of American Association of Cancer Research (AACR)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Reviving chemotherapy sensitivity after anti-CCR4 mAb (mogamulizumab) treatment in lung cancer patients.2017

    • Author(s)
      Kurose K, Ohue Y, Isobe M, Suzuki S, Wada H, Oka M, Ueda R, Nakayama E.
    • Organizer
      Third CRI-CIMT-EATI-AACR Second International Cancer Immunotherapy Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Reviving Chemotherapy Sensityvity after Anti-CCR4 mAb (Mogamulizumab) Treatment in Lung Cancer Patients.2017

    • Author(s)
      Kurose K, Ohue Y, Isobe M, Suzuki S, Wada H, Ueda R, Nakayama E, Oka M.
    • Organizer
      IASLC 18th World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Reviving chemotherapy sensitivity after anti-CCR4 mAb (mogamulizumab) treatment in lung cancer patients2017

    • Author(s)
      Kurose K, Ohue Y, Isobe M, Suzuki S, Wada H, Oka M, Ueda R, Nakayama E.
    • Organizer
      Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21533
  • [Presentation] Reviving chemotherapy sensitivity after anti-CCR4 mAb (mogamulizumab) treatment in lung cancer patients2017

    • Author(s)
      Koji Kurose, Yoshihiro Ohue, Midori Isobe, Susumu Suzuki, Hisashi Wada, Ryuzo Ueda, Eiichi Nakayama and Mikio Oka
    • Organizer
      IASLC 18th world conference on lung cancer(WCLC 2017)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21533
  • [Presentation] Reviving Chemotherapy Sensityvity after Anti-CCR4 mAb (Mogamulizumab) Treatment in Lung Cancer Patients.2017

    • Author(s)
      Kurose K, Ohue Y, Isobe M, Suzuki S, Wada H, Ueda R, Nakayama E, Oka M.
    • Organizer
      IASLC 18th World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Immuno-inhibitory pathway, TIM-3/Galectin-9, in lung adenocarcinoma: clinical and in vitro analysis.2017

    • Author(s)
      Oka M, Ohue Y, Kurose K, Nishio Y, Isobe M, Nakayama E.
    • Organizer
      101st Annual Meeting of American Association of Cancer Research
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] 腫瘍PD-L1,Gal-9,XAGE1発現及びT細胞浸潤を指標とした肺腺癌の予後予測2016

    • Author(s)
      大植祥弘, 黒瀬浩史, 西尾祐美, 磯辺みどり, 福岡順也, 中山睿一, 岡三喜男
    • Organizer
      第56回日本呼吸器学会学術講演会
    • Place of Presentation
      京都国際会館(京都)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Role of TIM-3/Galectin-9 pathway in lung adenocarcinoma2016

    • Author(s)
      Ohue Y, Kurose K, Nishio Y, Isobe M, Oka M and Nakayama E.
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] 肺腺癌のTIM-3/Galectin-9経路を介した免疫抑制と予後の関連2016

    • Author(s)
      大植祥弘, 黒瀬浩史, 磯辺みどり, 西尾祐美, 岡三喜男, 中山睿一
    • Organizer
      第20回日本がん免疫学会総会
    • Place of Presentation
      大阪国際交流センター(大阪)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] 肺腺癌のTIM-3/Galectin-9経路を介した免疫抑制と予後2016

    • Author(s)
      黒瀬浩史、大植祥弘、磯辺みどり、中山睿一、岡 三喜男
    • Organizer
      第57回日本肺癌学会総会
    • Place of Presentation
      福岡国際会議場(福岡市)
    • Year and Date
      2016-12-19
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Role of TIM-3/Galectin-9 pathway in lung adenocarcinoma.2016

    • Author(s)
      Ohue Y, Kurose K, Nishio Y, Isobe M, Oka M, Nakayama E.
    • Organizer
      CRI-CIMT-EATI-AACR Second International Cancer Immunotherapy Conference
    • Place of Presentation
      Nw York(米国)
    • Year and Date
      2016-09-25
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Role of TIM-3/Galectin-9 pathway in lung adenocarcinoma2016

    • Author(s)
      Ohue Y, Kurose K, Nishio Y, Isobe M, Oka M and Nakayama E.
    • Organizer
      CRI-CIMT-EATI-AACR Second International Cancer Immunotherapy Conference
    • Place of Presentation
      ニューヨーク(アメリカ)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Discriminant function for predicting survival of lung adenocarcinoma patients developed by using immune parameters of PD-L1,Gal-9, and XAGE1 expression on tumor cells and T cell infiltration score.2015

    • Author(s)
      Ohue Y, Kurose K, Oka M, Nakayama E.
    • Organizer
      The Inaugural International Cancer Immunotherapy Conference
    • Place of Presentation
      New York(米国)
    • Year and Date
      2015-09-16
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Phase Ⅰa study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients.2015

    • Author(s)
      Kurose K, Ohue Y, Wada H, Doi T, Nishikawa H, Oka M, Ueda R.
    • Organizer
      The Inaugural International Cancer Immunotherapy Conference
    • Place of Presentation
      New York(米国)
    • Year and Date
      2015-09-16
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K09235
  • [Presentation] Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb2013

    • Author(s)
      黒瀬浩史、大植祥弘、堅田洋佑、阿部公亮、磯辺みどり、松本博文、上中明子、中山睿一、岡三喜男
    • Organizer
      第54回日本肺癌学会総会
    • Place of Presentation
      東京
    • Year and Date
      2013-11-22
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb2013

    • Author(s)
      Kurose K, Ohue Y, Mizote Y, Isobe M, Uenaka A, Oka M, Nakayama E.
    • Organizer
      21st Annual Cancer Research Institute International Cancer Immunotherapy Symposium
    • Place of Presentation
      New York, USA
    • Year and Date
      2013-10-01
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Immune response to XAGE-1b (GAGED2a) in NSCLC patients and its clinical relevance2013

    • Author(s)
      Ohue Y, Kurose K, Eikawa S, Mizote Y, Matsumoto H, Isobe M, Uenaka A, Fukuda M, Nakayama E, Oka M.
    • Organizer
      104th Annual Meeting of American Association of Cancer Research (AACR)
    • Place of Presentation
      Washington DC, USA
    • Year and Date
      2013-04-07
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb2013

    • Author(s)
      Kurose K, Eikawa S, Mizote Y, Ohue Y, Isobe M, Uenaka A, Oka M, Nakayama E.
    • Organizer
      104th Annual Meeting of American Association of Cancer Research (AACR)
    • Place of Presentation
      Washington DC, USA
    • Year and Date
      2013-04-07
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Immune response to XAGE-1b (GAGED2a) in NSCLC patients and its clinical relevance2013

    • Author(s)
      大植祥弘、黒瀬浩史、松本博文、阿部公亮、堅田洋佑、磯辺みどり、上中明子、中山睿一、岡三喜男
    • Organizer
      第54回日本肺癌学会総会
    • Place of Presentation
      東京
    • Year and Date
      2013-11-22
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Prolonged overall survival in XAGE-1b (GAGED2a) antibody positive NSCLC patients2013

    • Author(s)
      Ohue Y, Kurose K, Mizote Y, Matsumoto H, Isobe M, Uenaka A, Fukuda M, Oka M, Nakayama E.
    • Organizer
      21st Annual Cancer Research Institute International Cancer Immunotherapy Symposium
    • Place of Presentation
      New York, USA
    • Year and Date
      2013-10-01
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Immune response to XAGE-1b(GAGED2a) in NSCLC patients and its clinical relevance2012

    • Author(s)
      Ohue Y, Eikawa S, Mizote Y, Matsumoto H, Isobe M, Uenaka A, Oka M, Nakayama E.
    • Organizer
      20th Annual International Cancer Immune- therapy Symposium
    • Place of Presentation
      New York, USA
    • Year and Date
      2012-10-01
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] 肺癌患者における癌微小環境中の免疫応答の解析2012

    • Author(s)
      松本博文、大植祥弘、榮川伸吾、溝手雄、磯辺みどり、上中明子、永安武、中山睿一、岡三喜男
    • Organizer
      第53回日本肺癌学会総会
    • Place of Presentation
      岡山
    • Year and Date
      2012-11-08
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Immunogenicity of cancer/testis antigen XAGE-1d in patients with non-small- cell lung cancer (NSCLC)2012

    • Author(s)
      Matsumoto H, Ohue Y, Eikawa S, Mizote Y, Kurose K, Isobe M, Uenaka A, Nagayasu T, Oka M, Nakayama E.
    • Organizer
      103rd Annual Meeting of American Association of Cancer Research (AACR)
    • Place of Presentation
      Chicago, USA
    • Year and Date
      2012-04-01
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Immunogenicity of cancer/testis antigen XAGE-1d in patients with non-small-cell lung cancer (NSCLC)2012

    • Author(s)
      Matsumoto H, Ohue Y, Eikawa S, Mizote Y, Kurose K, Isobe M, Uenaka A, Nagayasu T, Oka M, Nakayama E.
    • Organizer
      103rd Annual Meeting of American Association of Cancer Research
    • Place of Presentation
      McCormick Convention Center (Chicago, IL, USA)
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] 非小細胞肺がん患者におけるXAGE-1b免疫の頻度と強さ2012

    • Author(s)
      大植祥弘、榮川伸吾、黒瀬浩史、阿部公亮、橘高誠、池田征樹、清水大樹、毛利圭二、加藤茂樹、尾長谷靖、小橋吉博、中山睿一、岡三喜男
    • Organizer
      第53回日本肺癌学会総会
    • Place of Presentation
      岡山
    • Year and Date
      2012-11-08
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Treg depletion from PBMCs by treatment with defucosylated anti- human CCR4 mAb2012

    • Author(s)
      Kurose K, Eikawa S, Mizote Y, Ohue Y, Isobe M, Uenaka A, Oka M, Nakayama E.
    • Organizer
      20th Annual International Cancer Immune- therapy Symposium
    • Place of Presentation
      New York, USA
    • Year and Date
      2012-10-01
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Correlation of antibody and T-cell responses against XAGE-1b in NSCLC patients2012

    • Author(s)
      Ohue Y, Eikawa S, Mizote Y, Matsumoto H, Okazaki N, Isobe M, Uenaka A, Nakayama E, Oka M.
    • Organizer
      103rd Annual Meeting of American Association of Cancer Research (AACR)
    • Place of Presentation
      Chicago, USA
    • Year and Date
      2012-04-01
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Treg depletion from PBMCs by treatment with defucosylated anti-human CCR4 mAb2012

    • Author(s)
      Kurose K, Eikawa S, Mizote Y, Ohue Y, Isobe M, Uenaka A, Oka M, Nakayama E
    • Organizer
      20th Annual International Cancer Immunotherapy Symposium
    • Place of Presentation
      Millennium Conference Center (New York, NY, USA)
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Immune response to XAGE-1b (GAGED2a) in NSCLC patients and its clinical relevance2012

    • Author(s)
      Ohue Y, Eikawa S, Mizote Y, Matsumoto H, Isobe M, Uenaka A, Oka M, Nakayama E
    • Organizer
      20th Annual International Cancer Immunotherapy Symposium
    • Place of Presentation
      Millennium Conference Center (New York, NY, USA)
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] 非小細胞肺癌患者における癌精巣抗原XAGE-1dに対する免疫応答2012

    • Author(s)
      松本博文、大植祥弘、榮川伸吾、溝手雄、磯辺みどり、上中明子、永安武、中山睿一、岡三喜男
    • Organizer
      第53回日本肺癌学会総会
    • Place of Presentation
      岡山
    • Year and Date
      2012-11-08
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Correlation of antibody and T-cell responses against XAGE-1b in NSCLC patients2012

    • Author(s)
      Ohue Y, Eikawa S, Mizote Y, Matsumoto H, Okazaki N, Isobe M, Uenaka A, Nakayama E, Oka M
    • Organizer
      103rd Annual Meeting of American Association of Cancer Research
    • Place of Presentation
      McCormick Convention Center (Chicago, IL, USA)
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] 電子聴診器を用いた肺音検査システムの研究と開発2011

    • Author(s)
      宮原末治、岡三喜男
    • Organizer
      第36回肺音(呼吸音)研究会
    • Place of Presentation
      日本青年館(東京)
    • Year and Date
      2011-11-19
    • Data Source
      KAKENHI-PROJECT-20590937
  • [Presentation] Correlation of antibody and T-cell responses against XAGE-1b in NSCLC patients2011

    • Author(s)
      Ohue Y, Eikawa S, Mizote Y, Matsumoto H, Okazaki N, Isobe M, Uenaka A, Oka M, Nakayama E.
    • Organizer
      19th Annual Cancer Research Institute International Cancer Immunotherapy Symposium
    • Place of Presentation
      New York, USA
    • Year and Date
      2011-10-03
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Induction of CD8 T Cell Responses Restricted to Multiple HLA Class I Alleles in a Cancer Patient by Immunization with a 20-Mer NY-DSO-1 91-110) Peptide2011

    • Author(s)
      Eikawa S, Kakimi K, Isobe M, Kuzushima K, Ohue Y, Ikeuchi K, Uenaka A, Udono H, Lloyd Old, Oka M and Nakayama E.
    • Organizer
      19th Annual Cancer Research Institute International Cancer Immunotherapy Symposium
    • Place of Presentation
      New York, USA
    • Year and Date
      2011-10-03
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] 肺音聴診の教育用及び診療支援ソフトの新規開発2010

    • Author(s)
      大藤貴、岡三喜男
    • Organizer
      第50回日本呼吸器学会総会
    • Place of Presentation
      国立京都国際会館(京都)
    • Year and Date
      2010-04-24
    • Data Source
      KAKENHI-PROJECT-20590937
  • [Presentation] ピエゾ素子型電子聴診器によるリアルタイム肺音表示とCT画像2009

    • Author(s)
      岡三喜男, 他11名
    • Organizer
      日本呼吸器学会
    • Place of Presentation
      東京国際フォーラム(東京都)
    • Year and Date
      2009-06-12
    • Data Source
      KAKENHI-PROJECT-20590937
  • [Presentation] ピエゾ素子型電子聴診器によるリアルタイム肺音表示とCT画像2009

    • Author(s)
      岡三喜男
    • Organizer
      第49回日本呼吸器学会総会
    • Place of Presentation
      東京国際フォーラム(東京都)
    • Year and Date
      2009-06-12
    • Data Source
      KAKENHI-PROJECT-20590937
  • [Presentation] Correlation of antibody and T-cell responses against XAGE-1b in NSCLC patients

    • Author(s)
      Mikio Oka
    • Organizer
      19th Annual International Cancer Immunotherapy Symposium
    • Place of Presentation
      Millennium Conference Center (New York, USA)
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] 次世代がん治療としての分子免疫療法

    • Author(s)
      岡 三喜男
    • Organizer
      第53回 日本呼吸器学会学術講演会
    • Place of Presentation
      東京国際フォーラム、東京
    • Invited
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Immune response to XAGE-1b (GAGED2a) in NSCLC patients and its clinical relevance

    • Author(s)
      大植祥弘、黒瀬浩史、松本博文、阿部公亮、堅田洋佑、磯辺みどり、上中明子、福田実、中山睿一、岡 三喜男
    • Organizer
      第54回 日本肺癌学会総会
    • Place of Presentation
      ホテルニューオータニ東京、東京
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb.

    • Author(s)
      Kurose K, Ohue Y, Mizote Y, Isobe M, Uenaka A, Oka M, Nakayama E.
    • Organizer
      21st Annual Cancer Research Institute International Cancer Immunotherapy Symposium
    • Place of Presentation
      Grand Hyatt New York, New York, NY, USA
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb.

    • Author(s)
      Kurose K, Eikawa S, Mizote Y, Ohue Y, Isobe M, Uenaka A, Oka M, Nakayama E.
    • Organizer
      104th Annual Meeting of American Association of Cancer Research (AACR)
    • Place of Presentation
      Convention Center, Washington DC, USA
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Immune response to XAGE-1b (GAGED2a) in NSCLC patients and its clinical relevance.

    • Author(s)
      Ohue Y, Kurose K, Eikawa S, Mizote Y, Matsumoto H, Isobe M, Uenaka A, Fukuda M, Nakayama E, Oka M.
    • Organizer
      104th Annual Meeting of American Association of Cancer Research (AACR)
    • Place of Presentation
      Convention Center, Washington DC, USA
    • Data Source
      KAKENHI-PROJECT-23591169
  • [Presentation] Prolonged overall survival in XAGE-1b (GAGED2a) antibody positive NSCLC patients.

    • Author(s)
      Ohue Y, Kurose K, Mizote Y, Matsumoto H, Isobe M, Uenaka A, Fukuda M, Oka M, Nakayama E.
    • Organizer
      21st Annual Cancer Research Institute International Cancer Immunotherapy Symposium
    • Place of Presentation
      Grand Hyatt New York, New York, NY, USA
    • Data Source
      KAKENHI-PROJECT-23591169
  • 1.  Kurose KOJI (30551139)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 18 results
  • 2.  Ohue Yoshihiro (70435014)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 14 results
  • 3.  SODA Hiroshi (60244042)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 20 results
  • 4.  Nakayama Eiichi (60180428)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 6 results
  • 5.  田中 了 (70412187)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  塩見 達志 (60366127)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  杉山 聖子 (70793628)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  青山 裕美 (90291393)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  土岐 祐一郎
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 10.  西川 博嘉
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 11.  垣見 和宏
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi